Patheon N.V., a global provider of high-quality drug development and delivery solutions to the pharmaceutical sector, announced that it expects to invest approximately $45 million at key sites across its global network to meet growing demand for expanded service capabilities. “As outsourcing of Pharma development and manufacturing services continues to grow, our customers will need even more advanced…
Patheon Named Supply Chain Resiliency Partner of the Year
Patheon Completes Acquisition of Manufacturing Site from Roche
Patheon announces completion of its acquisition of state-of-the-art manufacturing site. Patheon N.V., a global provider of high-quality drug development and delivery for the pharmaceutical and biopharma sectors, announced that it has completed the acquisition of a state-of-the-art manufacturing facility in Florence, SC from Roche Holdings, Inc. Patheon has begun integrating the site into the Patheon network. The…
CDMO Patheon to Acquire State-of-the-Art Manufacturing Site
Patheon N.V., a global provider of high-quality drug development and delivery solutions to the pharmaceutical and biopharma sectors, announced that it has signed a definitive agreement to acquire a state-of-the-art active pharmaceutical ingredients (API) manufacturing facility in Florence, SC, from Roche Holdings, Inc., an indirect, wholly owned subsidiary of Roche Holding Ltd., which it will integrate…